SOX17 and pulmonary arterial hypertension: A recent large genome-wide association study (GWAS), using data from 11,744 European individuals (2,085 patients) identified two independent PAH risk variant-containing signals (SOX17-signal 1 and SOX17-signal 2) in a region located 106-200kb upstream of the SOX17 gene promoter.